| Ytd | 22.84% | |
| 1y | 22.84% |
| Open | 28.77 | Prev Close | 28.74 | Low | 28.50 | High | 29.18 | Mkt Cap | 6.15B |
| Vol | 856.31K | Avg Vol | 1.26M | EPS | -0.36 | P/E | N/A | Forward P/E | 135.99 |
| Beta | 2.16 | Short Ratio | 1.93 | Inst. Own | 26.19% | Dividend | 0.57 | Div Yield | 1.98 |
| Ex Div Date | 06-12 | Earning | 08-04 | 50-d Avg | 26.40 | 200-d Avg | 25.71 | 1yr Est | 30.18 |
Janus Living, recently spun off from Healthpeak Properties, presents a new REIT opportunity in the s
Scotiabank analyst Nicholas Yulico maintains Janus Living (NYSE:JAN) with a Sector Outperform and
Raymond James analyst David Rodgers initiates coverage on Janus Living (NYSE:JAN) with a Strong B
Cantor Fitzgerald analyst Richard Anderson reiterates Janus Living (NYSE:JAN) with a Overweight a
Keybanc analyst Austin Wurschmidt maintains Janus Living (NYSE:JAN) with a Overweight and raises
Wells Fargo analyst John Kilichowski maintains Janus Living (NYSE:JAN) with a Overweight and rais
https://www.sec.gov/ix?doc=/Archives/edgar/data/2100805/000110465926068606/tmb-20260331xs11.htm
Scotiabank analyst Nicholas Yulico maintains Janus Living (NYSE:JAN) with a Sector Outperform and
Barclays analyst Richard Hightower maintains Janus Living (NYSE:JAN) with a Overweight and raises
RBC Capital analyst Michael Carroll maintains Janus Living (NYSE:JAN) with a Outperform and raise
Janus Living (NYSE:JAN) reported quarterly earnings of $0.23 per share which beat the analyst consen
BNP Paribas analyst Nate Crossett initiates coverage on Janus Living (NYSE:JAN) with a Outperform
Goldman Sachs analyst Julien Blouin initiates coverage on Janus Living (NYSE:JAN) with a Neutral
RBC Capital analyst Michael Carroll initiates coverage on Janus Living (NYSE:JAN) with a Outperfo
Wells Fargo analyst John Kilichowski initiates coverage on Janus Living (NYSE:JAN) with a Overwei
Barclays analyst Richard Hightower initiates coverage on Janus Living (NYSE:JAN) with a Overweigh
JP Morgan analyst Michael Mueller initiates coverage on Janus Living (NYSE:JAN) with a Overweight
Top Wall Street analysts changed outlook on top names. See all changes, including upgrades/downgrade
Keybanc analyst Austin Wurschmidt initiates coverage on Janus Living (NYSE:JAN) with a Overweight
Morgan Stanley analyst Ronald Kamdem initiates coverage on Janus Living (NYSE:JAN) with a Overwei
Cantor Fitzgerald analyst Richard Anderson initiates coverage on Janus Living (NYSE:JAN) with a O
Real estate stocks flashing warning for momentum investors. RSI above 70 for Janus Living (JAN) and
https://www.bloomberg.com/news/articles/2026-03-19/janus-living-ipo-said-to-hit-840-million-price-at
JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on fintech and healthcare, c
JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on healthcare and fintech, a
JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on healthcare and fintech, a
At closing, JanOne will issue to the former stockholders of ALT 5 1,799,100 shares of its common sto
ALT 5's transactional processing volume exceeded $1.1 billion in calendar 2023, and over $450 mi